Accordingly, 19.4% and 18.7% of the overall number of CD4+ and CD8+ lymphocytes, respectively, were located at vascular sites where a higher CD4-to-CD8 ratio (1.15) compared to that observed at tumor site (IT, 0.89) was detected (Table 3; Figure 1). This evidence concerns the gene CD8A and neoplasm.